Life2 Completes $1.5M Series A Funding

Life2, Inc., a ST. Simon’s Island, GA-based provider of in healthcare analytics & clinical data services, closed a $1.5M Series A funding.

Morley Device Innovations (MDI) was the sole new investor and Managing Director Donald A. Johnson will join the Board of Directors.

The company intends to use the additional funds for sales growth and product development of its suite.

Led by Sam Wilkes, Founder and Chairman, Life2 has developed a proprietary risk mitigation platform for the healthcare industry. Its Length of Stay Optimization suite focuses on the myriad financial and operational risks giving hospitals a prospective look into the future, a daily cycle of new insights, patient based risk stratification, causality determination for selecting actionable interventions and an automated feedback loop for knowing which actions work and which ones do not.



Join the discussion